RNA-Sequencing & Analysis (RNA-seq) Market, By Product and Services (RNA Sequencing Platforms and Consumables, Sample Preparation Products, RNA Sequencing Services, Data Analysis, Storage and Management),Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing), Application (Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics), End User (Research and Academia, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End Users) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
The Global RNA-Sequencing & Analysis (RNA-seq) Market size was estimated at USD 2.8 billion in 2022 and is projected to reach USD 8.7 billion in 2030 at a CAGR of 17.7% during the forecast period 2023-2030.
RNA-seq is a widely used technique that provides comprehensive insights into the genomic makeup of an organism or cell. This technique is used in both traditional and non-traditional applications, such as identifying gene expression patterns, detecting mutations, and studying epigenetic modifications. The demand for better sequencing-based diagnostics has led to the development of novel sequencing technologies that can provide more accurate and reliable results. High-throughput sequencers and portable units are two examples of such technologies that have become increasingly popular due to their ability to generate large amounts of data quickly and efficiently.
Next-generation sequencing (NGS) technology is a relatively new technology that has gained immense popularity since its launch due to its ability to provide advanced and comprehensive genetic insights. NGS technology is widely used in both traditional and non-traditional applications, such as in research, clinical diagnostics, and personalized medicine, to analyze DNA and RNA sequences. The growing demand for enhanced sequencing-based diagnostics has led to the development of new sequencing technologies that offer improved accuracy, speed, and cost-effectiveness.
RNA sequencing is a technique used to determine the sequence of nucleotides in RNA molecules, which can provide valuable information about the virus's genetic makeup. Single-cell RNA sequencing, stranded RNA sequencing, and ultra-low input RNA sequencing are different methods used to study the virus's features and epidemiology across diverse countries. Single-cell RNA sequencing allows researchers to study individual cells and their gene expression patterns, while stranded RNA sequencing can determine the directionality of RNA molecules. Ultra-low input RNA sequencing is used when only a small amount of RNA is available for analysis.
Next-generation sequencing (NGS) is a high-throughput DNA sequencing technology that has revolutionized the field of genomics. Paired-end (PE) sequencing is a type of NGS that allows for the simultaneous sequencing of both ends of DNA fragments in a library. This technique produces twice as many reads as single-end sequencing, which only sequences one end of the DNA fragment. The forward and reverse reads produced by PE sequencing are aligned as reading pairs, which improves the accuracy of read alignment and enables the detection of insertions and deletions (indels) in the DNA sequence. Indels are important genetic variations that can cause diseases or affect an individual's response to drugs. The ability to detect indels is not achievable with single-read data, which makes PE sequencing a more powerful tool for genomic research. The paired-end strategy is the most modern and well-liked technique among researchers because of its ability to produce high-quality sequencing data and detect genetic variations that are not detectable by other sequencing methods.
North America to Dominate the Market
Report Feature |
Descriptions |
---|---|
Growth Rate |
CAGR of 17.7% during the forecasting period, 2023-2030 |
Historical Data |
2019-2021 |
Forecast Years |
2023-2030 |
Base Year |
2022 |
Units Considered |
Revenue in USD billion and CAGR from 2023 to 2030 |
Report Segmentation |
by product service, Technology, Application, End-User and region. |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East, and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, and South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Illumina Inc.; Thermo Fischer Scientific Inc.; Oxford Nanopore Technologies plc; Agilent Technologies, Inc.; BGI; PerkinElmer Inc.; QIAGEN; Eurofins Scientific; F. Hoffmann-La Roche Ltd; Takara Bio Inc.; GENEWIZ, Inc.; Hamilton Company; Macrogen Inc.; Zymo Research Corporation; Tecan Trading AG |
Available Customization |
In addition to the market data for the RNA-sequencing & analysis (RNA-seq) Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements. |
The RNA-Sequencing & Analysis (RNA-seq) Market is segmented into various segments such as by Product service, Technology, Application, End-User and Region:
Based on Product service
Based on the Technology
Based on the Application
Based on End-User
Based on Region
The prominent players in the RNA-sequencing & analysis (RNA-seq) market are